Zobrazeno 1 - 10
of 59
pro vyhledávání: '"COVID-19 treatments"'
Autor:
Justin M. Luningham, Idara N. Akpan, Sarah Alkhatib, Tanjila Taskin, Palak Desai, Jamboor K. Vishwanatha, Erika L. Thompson
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTThe COVID-19 pandemic required the rapid development of COVID-19 vaccines and treatments, necessitating quick yet representative clinical trial enrollment to evaluate these preventive measures. However, misinformation around the COVID-19 pand
Externí odkaz:
https://doaj.org/article/f25357dc8a4d48609e00af7509fc584d
Autor:
Stefania Bellino
Publikováno v:
Annals of Medicine, Vol 54, Iss 1, Pp 2856-2860 (2022)
Background The COVID-19 pandemic caused by SARS-CoV-2 continues to have a serious impact on public health worldwide. Most patients develop mild to moderate symptoms and recover without requiring special treatment, but up to 15% develop severe (dyspne
Externí odkaz:
https://doaj.org/article/6be14f5946ea4473904510b3473a565a
Autor:
Totan Garai, Harish Garg
Publikováno v:
Results in Control and Optimization, Vol 12, Iss , Pp 100242- (2023)
The entire world is currently fighting the severe and dangerous pandemic COVID-19, which is causing bodily suffering and mental distress due to the rapidly increasing number of infected patients and deaths worldwide. Many COVID-19 treatments are goin
Externí odkaz:
https://doaj.org/article/92796860d8cf4a308fbd41ddb0b2ea2a
Publikováno v:
International Journal of Infectious Diseases, Vol 122, Iss , Pp 72-80 (2022)
ABSTRACT: Objectives: This study aimed to describe the prevalence of risks of bias in randomized trials of therapeutic interventions for COVID-19. Methods: Systematic review and risk of bias assessment performed by two independent reviewers of a rand
Externí odkaz:
https://doaj.org/article/5b55bdbc7ae84b9bb88ab8b2ebb9eb93
Publikováno v:
F1000Research, Vol 12 (2023)
Background: A coronavirus identified in 2019, SARS-CoV-2, has caused a pandemic of respiratory illness, called COVID-19. Most people with COVID-19 experience mild to moderate symptoms and recover without the need for special treatments. The SARS‑Co
Externí odkaz:
https://doaj.org/article/41fff7037fc241d78b3076008fa6cc46
Autor:
Yue Li, Ashley Duche, Michael R. Sayer, Don Roosan, Farid G. Khalafalla, Rennolds S. Ostrom, Jennifer Totonchy, Moom R. Roosan
Publikováno v:
BMC Genomics, Vol 22, Iss 1, Pp 1-13 (2021)
Abstract Background The ongoing COVID-19 outbreak has caused devastating mortality and posed a significant threat to public health worldwide. Despite the severity of this illness and 2.3 million worldwide deaths, the disease mechanism is mostly unkno
Externí odkaz:
https://doaj.org/article/ddecfce575344945b0ca7c9a16bb82a4
Autor:
Sarah I Y Ahmed
Publikováno v:
Sudan Journal of Medical Sciences, Vol 15, Pp 378-382 (2020)
Background: Angiotensin-converting enzyme 2 (ACE2) is recognized as the main cellular receptor for the new coronavirus, SARS-CoV-2, that facilitates its entry into the host target cell, leading to the fatal viral infection, coronavirus disease 2019 (
Externí odkaz:
https://doaj.org/article/574ad1825ad64655929a505c36e6d6c2
Autor:
Jaak Järv, Aleksei Kuznetsov
Publikováno v:
Proceedings of the Estonian Academy of Sciences, Vol 69, Iss 3, Pp 228-234 (2020)
Among different approaches to control the COVID-19 disease, there is clear interest to develop inhibitors which block the virus interaction with the host cells and through this simple mechanism could facilitate developing medication. In this report,
Externí odkaz:
https://doaj.org/article/80da16ac9f2d40198de481690eb55054
Autor:
Judit Aranda, Jose Loureiro-Amigo, Anna Murgadella, Núria Vàzquez, Lucía Feria, Miriam Muñoz, Ariadna Padulles, Gabriela Abelenda, Carol Garcia-Vidal, Montse Tuset, Marta Albanell, Lucía Boix-Palop, Núria Sanmartí-Martínez, Sílvia Gómez-Zorrilla, Daniel Echeverria-Esnal, Alicia Rodriguez-Alarcón, Beatriz Borjabad, Ana Coloma, Jordi Carratalà, Isabel Oriol
Publikováno v:
Antibiotics, Vol 12, Iss 5, p 809 (2023)
Aim: To analyze trends in the prescription of COVID-19 treatments for hospitalized patients during the pandemic. Methods: Multicenter, ecological, time-series study of aggregate data for all adult patients with COVID-19 treated in five acute-care hos
Externí odkaz:
https://doaj.org/article/175c773880f442ac9edbe966012f44fa
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.